JPRN-UMIN000041992尚未招募未知
Efficacy and safety of low dose Colchicine in patients with atherothrombotic brain infarction and gout or hyperuricemia - Efficacy and safety of low dose Colchicine in patients with atherothrombotic brain infarction and gout or hyperuricemia
Japanese Red Cross Kyoto Daini Hospital0 个研究点目标入组 160 人开始时间: 2020年10月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.pre mRS more than 3 2.Have a potential cardiac source of embolism 3.suspect of arterial dissection. 4.unavailable to MRI. 5.Life expectancy less than 1 year. 6.Contraindicated for Colchicine. 7.Patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study.
研究者
相似试验
招募中
3 期
Evaluation of the colchicine on the myocardial infarctiomyocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20231001059578N1Ghoum University of Medical Sciences180
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
招募中
3 期
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140
招募中
2 期
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillatioAtrial Fibrillation.Unspecified atrial fibrillationI48.91IRCT20200328046886N6Mazandaran University of Medical Sciences172
招募中
2 期
Efficacy of Colchicine in Treatment of Covid-19Covid 19.Coronavirus as the cause of diseases classified elsewhereB97.2IRCT20201229049872N1Artesh University of Medical Sciences80